Pressor response to intravenous tyramine is a marker of cardiac, but not vascular, adrenergic function

• Published in: Journal of cardiovascular pharmacology Vol. 41; no. 1; p. 126
• Main Authors: Meck, Janice V, Martin, David S, D'Aunno, Dominick S, Waters, Wendy W
• Format: Journal Article
• Language: English
• Published: United States 01.01.2003
• Subjects: Adult; Hemodynamics - drug effects; Humans; Injections, Intravenous; Popliteal Artery - diagnostic imaging; Popliteal Artery - drug effects; Pressoreceptors - drug effects; Tyramine - pharmacology; Ultrasonography; NASA Discipline Cardiopulmonary; NASA Center JSC
• ISSN: 0160-2446; 1533-4023
• DOI: 10.1097/00005344-200301000-00016

Intravenous injections of the indirect sympathetic amine, tyramine, are used as a test of peripheral adrenergic function. The authors measured the time course of increases in ejection fraction, heart rate, systolic and diastolic pressure, popliteal artery flow, and greater saphenous vein diameter before and after an injection of 4.0 mg/m(2) body surface area of tyramine in normal human subjects. The tyramine caused moderate, significant increases in systolic pressure and significant decreases in total peripheral resistance. The earliest changes were a 30% increase in ejection fraction and a 16% increase in systolic pressure, followed by a 60% increase in popliteal artery flow and a later 11% increase in greater saphenous vein diameter. There were no changes in diastolic pressure or heart rate. These results suggest that pressor responses during tyramine injections are primarily due to an inotropic response that increases cardiac output and pressure and causes a reflex decrease in vascular resistance. Thus, tyramine pressor tests are a measure of cardiac, but not vascular, sympathetic function.